Evexia Lifecare Limited has delivered impressive financial performance for the third quarter of FY2026, with the Board of Directors approving unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025. The results were approved during a board meeting held on February 17, 2026, which was adjourned from February 14, 2026.

Strong Quarterly Performance

The company demonstrated robust growth in its standalone operations during Q3FY26. Net profit surged significantly compared to the previous year, while revenue from operations showed healthy expansion despite some sequential moderation.

Nine-Month Performance Highlights

For the nine-month period from April 1, 2025 to December 31, 2025, the company maintained its growth trajectory across key financial parameters.

Consolidated Results Overview

The consolidated financial results also reflected positive performance, incorporating results from seven subsidiaries across India, UK, and Tongo. The consolidated net profit for Q3FY26 stood at ₹29.19 lakhs compared to ₹11.75 lakhs in Q3FY25, representing substantial year-on-year growth.

Operational Efficiency

The company's expense management remained disciplined during the quarter. Total expenses for Q3FY26 standalone operations were ₹2,430.84 lakhs compared to ₹2,141.98 lakhs in the previous year. The profit before tax increased to ₹55.04 lakhs from ₹25.99 lakhs, demonstrating improved operational efficiency.

Board Meeting and Regulatory Compliance

The board meeting commenced at 04:00 p.m. and concluded at 05:30 p.m. on February 17, 2026. The meeting was presided over by Chairman & Managing Director Jitesh Raichandbhai Thakkar (DIN: 01631093). The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by statutory auditors Tejas K. Soni and Company, Chartered Accountants. The results comply with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The company maintains a paid-up equity share capital of ₹18,773.28 lakhs with a face value of ₹1 per share.

Evexia Lifecare Limited, a company listed on the Bombay Stock Exchange (BSE), has undergone a significant change in its shareholding structure following a reclassification approved by the BSE. The move has resulted in a decrease in the company's promoter shareholding and a corresponding increase in public shareholding.

Reclassification Details

The BSE has approved the reclassification of three individuals from Evexia Lifecare's promoter group to the public category. The reclassification was carried out under Regulation 31A of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The individuals reclassified are:

1. Santosh Kahar: 12,73,330 shares (0.07% of total shareholding)
2. Mitul Jagdish Thakkar: 9,33,320 shares (0.05% of total shareholding)
3. Patel Bharatbhai Limjibhai: 2,00,000 shares (0.01% of total shareholding)

In total, 24,06,650 shares, representing 0.13% of the company's total shareholding, were reclassified from the promoter group to the public category.

Impact on Shareholding Structure

The reclassification has led to notable changes in Evexia Lifecare's shareholding structure:

As a result of this reclassification:

• The promoter shareholding has decreased from 3.49% to 3.36% of the total shares.
• Public shareholding has increased from 96.51% to 96.64%.

Official Approval and Notification

The reclassification was officially approved by the BSE Limited through an approval letter (no. LIST/COMP/DN/385/2025-26) dated August 18, 2025. Evexia Lifecare Limited promptly informed the BSE about this development on the same day.

Jayeshbhai R. Thakkar, the Chairman & Managing Director of Evexia Lifecare Limited, signed the official intimation to the BSE, confirming the company's compliance with the regulatory requirements for such reclassifications.

This reclassification marks a shift in the company's ownership structure, potentially impacting its governance and public perception. Investors and market watchers may want to take note of this change in Evexia Lifecare's shareholding pattern.